These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 16159089)
1. Reduction of pulmonary edema after SAH with a pulmonary artery catheter-guided hemodynamic management protocol. Kim DH; Haney CL; Van Ginhoven G Neurocrit Care; 2005; 3(1):11-5. PubMed ID: 16159089 [TBL] [Abstract][Full Text] [Related]
2. A multicenter prospective cohort study of volume management after subarachnoid hemorrhage: circulatory characteristics of pulmonary edema after subarachnoid hemorrhage. Obata Y; Takeda J; Sato Y; Ishikura H; Matsui T; Isotani E J Neurosurg; 2016 Aug; 125(2):254-63. PubMed ID: 26613172 [TBL] [Abstract][Full Text] [Related]
3. Performance of bedside transpulmonary thermodilution monitoring for goal-directed hemodynamic management after subarachnoid hemorrhage. Mutoh T; Kazumata K; Ishikawa T; Terasaka S Stroke; 2009 Jul; 40(7):2368-74. PubMed ID: 19461028 [TBL] [Abstract][Full Text] [Related]
4. Circulatory characteristics of normovolemia and normotension therapy after subarachnoid hemorrhage, focusing on pulmonary edema. Sato Y; Isotani E; Kubota Y; Otomo Y; Ohno K Acta Neurochir (Wien); 2012 Dec; 154(12):2195-202. PubMed ID: 22972633 [TBL] [Abstract][Full Text] [Related]
5. [Intensive care using hypervolemic hypertensive hemodilution in the acute period of subarachnoidal hemorrhages in patients with arterial aneurysms]. Kurdiumova NV; Parfenov AL; Fokin MS; Grinenko EA; Eliava ShSh; Kheĭreddin AS; Sazonov IA Zh Vopr Neirokhir Im N N Burdenko; 2006; (2):48-53. PubMed ID: 16827430 [TBL] [Abstract][Full Text] [Related]
6. Neurogenic pulmonary edema and other mechanisms of impaired oxygenation after aneurysmal subarachnoid hemorrhage. Vespa PM; Bleck TP Neurocrit Care; 2004; 1(2):157-70. PubMed ID: 16174911 [TBL] [Abstract][Full Text] [Related]
7. Reconsideration of Neurogenic Pulmonary Edema as Source of Metastatic Cerebral Abscess Following Subarachnoid Hemorrhages: A Preliminary Study. Gökyar A; Aydın MD; Özmen S; Demirci E; Marangoz AH; Kuruoğlu E; Çokluk C World Neurosurg; 2018 Jul; 115():e476-e481. PubMed ID: 29684516 [TBL] [Abstract][Full Text] [Related]
9. Haemodynamic augmentation in the treatment of vasospasm in aneurysmal subarachnoid hemorrhage. Gura M; Elmaci I; Cerci A; Sagiroglu E; Coskun KK Turk Neurosurg; 2012; 22(4):435-40. PubMed ID: 22843460 [TBL] [Abstract][Full Text] [Related]
10. Effects of hypervolemia and hypertension on regional cerebral blood flow, intracranial pressure, and brain tissue oxygenation after subarachnoid hemorrhage. Muench E; Horn P; Bauhuf C; Roth H; Philipps M; Hermann P; Quintel M; Schmiedek P; Vajkoczy P Crit Care Med; 2007 Aug; 35(8):1844-51; quiz 1852. PubMed ID: 17581487 [TBL] [Abstract][Full Text] [Related]
11. Safety of hypertensive hypervolemic therapy with phenylephrine in the treatment of delayed ischemic deficits after subarachnoid hemorrhage. Miller JA; Dacey RG; Diringer MN Stroke; 1995 Dec; 26(12):2260-6. PubMed ID: 7491647 [TBL] [Abstract][Full Text] [Related]
15. Arginine vasopressin as a supplementary vasopressor in refractory hypertensive, hypervolemic, hemodilutional therapy in subarachnoid hemorrhage. Muehlschlegel S; Dunser MW; Gabrielli A; Wenzel V; Layon AJ Neurocrit Care; 2007; 6(1):3-10. PubMed ID: 17356185 [TBL] [Abstract][Full Text] [Related]
16. Molsidomine for the prevention of vasospasm-related delayed ischemic neurological deficits and delayed brain infarction and the improvement of clinical outcome after subarachnoid hemorrhage: a single-center clinical observational study. Ehlert A; Schmidt C; Wölfer J; Manthei G; Jacobs AH; Brüning R; Heindel W; Ringelstein EB; Stummer W; Pluta RM; Hesselmann V J Neurosurg; 2016 Jan; 124(1):51-8. PubMed ID: 26162034 [TBL] [Abstract][Full Text] [Related]
17. Optimal range of global end-diastolic volume for fluid management after aneurysmal subarachnoid hemorrhage: a multicenter prospective cohort study. Tagami T; Kuwamoto K; Watanabe A; Unemoto K; Yokobori S; Matsumoto G; Yokota H; Crit Care Med; 2014 Jun; 42(6):1348-56. PubMed ID: 24394632 [TBL] [Abstract][Full Text] [Related]
18. [Measurement of serum colloid oncotic pressure as a parameter of hemodilution and hemoconcentration in hypervolemic-hyperdynamic therapy for symptomatic vasospasm]. Tone O; Ito U; Tomita H; Masaoka H; Tominaga B No Shinkei Geka; 1993 May; 21(5):437-41. PubMed ID: 8321402 [TBL] [Abstract][Full Text] [Related]
19. Global end-diastolic volume is associated with the occurrence of delayed cerebral ischemia and pulmonary edema after subarachnoid hemorrhage. Watanabe A; Tagami T; Yokobori S; Matsumoto G; Igarashi Y; Suzuki G; Onda H; Fuse A; Yokota H Shock; 2012 Nov; 38(5):480-5. PubMed ID: 22832713 [TBL] [Abstract][Full Text] [Related]
20. Intracranial complications of hypervolemic therapy in patients with a delayed ischemic deficit attributed to vasospasm. Shimoda M; Oda S; Tsugane R; Sato O J Neurosurg; 1993 Mar; 78(3):423-9. PubMed ID: 8433144 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]